These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30787204)

  • 1. Towards a more precise and individualized assessment of breast cancer risk.
    Wood ME; Farina NH; Ahern TP; Cuke ME; Stein JL; Stein GS; Lian JB
    Aging (Albany NY); 2019 Feb; 11(4):1305-1316. PubMed ID: 30787204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk scores and breast cancer risk prediction.
    Roberts E; Howell S; Evans DG
    Breast; 2023 Feb; 67():71-77. PubMed ID: 36646003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-related single-nucleotide polymorphisms and breast cancer.
    Bahreini F; Rayzan E; Rezaei N
    J Cell Physiol; 2021 Mar; 236(3):1593-1605. PubMed ID: 32716070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
    Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
    Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability to predict breast cancer in Asian women using a polygenic susceptibility model.
    Hartman M; Suo C; Lim WY; Miao H; Teo YY; Chia KS
    Breast Cancer Res Treat; 2011 Jun; 127(3):805-12. PubMed ID: 21153878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
    Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
    Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
    Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
    Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
    Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
    Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.
    Wong XY; Chong KJ; van Til JA; Wee HL
    BMC Cancer; 2017 Nov; 17(1):776. PubMed ID: 29162038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors.
    Wilk G; Braun R
    PLoS Genet; 2018 Dec; 14(12):e1007837. PubMed ID: 30557297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of microRNA-423 Gene Variability in Breast Cancer Progression in Saudi Arabia.
    Mir R; Al Balawi IA; Duhier FMA
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2581-2589. PubMed ID: 30256064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of correlation between genetic variants in three microRNA genes (hsa-miR-146a, hsa-miR-502 binding site, hsa-miR-27a) and breast cancer risk.
    Parchami Barjui S; Reiisi S; Ebrahimi SO; Shekari B
    Curr Res Transl Med; 2017 Nov; 65(4):141-147. PubMed ID: 29128203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population.
    Morales S; Gulppi F; Gonzalez-Hormazabal P; Fernandez-Ramires R; Bravo T; Reyes JM; Gomez F; Waugh E; Jara L
    BMC Genet; 2016 Jul; 17(1):109. PubMed ID: 27421647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNPs related to vitamin D and breast cancer risk: a case-control study.
    Huss L; Butt ST; Almgren P; Borgquist S; Brandt J; Försti A; Melander O; Manjer J
    Breast Cancer Res; 2018 Jan; 20(1):1. PubMed ID: 29291743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study.
    Jedlinski DJ; Gabrovska PN; Weinstein SR; Smith RA; Griffiths LR
    Twin Res Hum Genet; 2011 Oct; 14(5):417-21. PubMed ID: 21962133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-microRNA signature predicts clinical outcome in breast cancer patients.
    Cheng D; He H; Liang B
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6386-6395. PubMed ID: 30338807
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.